Tom Krohn

Tom Krohn serves as the Global Pharma Commercial Lead at Viz.ai since June 2022, focusing on business development for pharmaceutical and biotech sectors utilizing advanced AI technologies. In April 2022, Tom founded The Krohn Group LLC, offering personalized consulting services. Prior to these roles, Tom was the Chief Development Officer at Antidote.me from January 2015 to April 2022, driving strategic collaborations and product development. Tom's extensive experience at Eli Lilly from June 2002 to January 2015 included senior director positions in clinical development and innovation, as well as IT strategy, contributing to significant advancements in clinical trials and operational efficiency. Earlier career highlights include a decade as General Manager at SALFA Madagascar and roles as a pharmacist and pharmacy information systems consultant. Tom holds an MBA in Business - Information Management from Texas McCombs School of Business and a BS in Pharmacy from North Dakota State University.